These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29616369)

  • 1. Treatment response assessment with (R)-[
    Tegnebratt T; Lu L; Eksborg S; Chireh A; Damberg P; Nikkhou-Aski S; Foukakis T; Rundqvist H; Holmin S; Kuiper RV; Samen E
    EJNMMI Res; 2018 Apr; 8(1):25. PubMed ID: 29616369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ.
    Samén E; Lu L; Mulder J; Thorell JO; Damberg P; Tegnebratt T; Holmgren L; Rundqvist H; Stone-Elander S
    EJNMMI Res; 2014 Mar; 4(1):17. PubMed ID: 24670127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2.
    Samén E; Thorell JO; Lu L; Tegnebratt T; Holmgren L; Stone-Elander S
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1283-95. PubMed ID: 19288096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice.
    Chen Y; Wang L; Liu H; Song F; Xu C; Zhang K; Chen Q; Wu S; Zhu Y; Dong Y; Zhou M; Zhang H; Tian M
    Mol Imaging Biol; 2018 Apr; 20(2):309-317. PubMed ID: 28795272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
    Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
    Tian M; Yu L; Zhang Y; Gao X
    Acad Radiol; 2012 Apr; 19(4):420-6. PubMed ID: 22444673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
    Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
    BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (18)F-FET and (18)F-FLT small animal PET for the assessment of anti-VEGF treatment response in an orthotopic model of glioblastoma.
    Nedergaard MK; Michaelsen SR; Perryman L; Erler J; Poulsen HS; Stockhausen MT; Lassen U; Kjaer A
    Nucl Med Biol; 2016 Mar; 43(3):198-205. PubMed ID: 26924500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of F18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Markers of Graft Viability in Anterior Cruciate Ligament Reconstruction.
    Garika SS; Sharma A; Razik A; Sharma A; Pandey RM; Gamanagatti S; Kumar R; Mittal R
    Am J Sports Med; 2019 Jan; 47(1):88-95. PubMed ID: 30481047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
    Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
    Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model.
    Wu D; Zheng Y; Hu X; Fan Z; Jing X
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():68-75. PubMed ID: 26042692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.
    Kostakoglu L; Duan F; Idowu MO; Jolles PR; Bear HD; Muzi M; Cormack J; Muzi JP; Pryma DA; Specht JM; Hovanessian-Larsen L; Miliziano J; Mallett S; Shields AF; Mankoff DA;
    J Nucl Med; 2015 Nov; 56(11):1681-9. PubMed ID: 26359256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FET microPET and microMRI for anti-VEGF and anti-PlGF response assessment in an orthotopic murine model of human glioblastoma.
    Nedergaard MK; Michaelsen SR; Urup T; Broholm H; El Ali H; Poulsen HS; Stockhausen MT; Kjaer A; Lassen U
    PLoS One; 2015; 10(2):e0115315. PubMed ID: 25680186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bu-zhong-yi-qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model.
    Ouyang M; Liu Y; Tan W; Xiao Y; Yu K; Sun X; Huang Y; Cheng J; Luo R; Zhao X
    BMC Complement Altern Med; 2014 Dec; 14():497. PubMed ID: 25511260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.